Literature DB >> 1914819

Pathogenesis of NIDDM in Pima Indians.

C Bogardus1, S Lillioja, P H Bennett.   

Abstract

The Pima Indians of Arizona have the highest reported prevalence and incidence of non-insulin-dependent diabetes mellitus (NIDDM) of any population in the world. A cross-sectional and longitudinal study was begun in 1982 to determine the metabolic characteristic(s) that is (are) predictive of the development of NIDDM and to document the sequence of metabolic events that occur with the transition from normal to impaired glucose tolerance and then to diabetes. Preliminary analyses suggest that insulin resistance is a primary abnormality predisposing Pima Indians to develop impaired glucose tolerance, and that the development of diabetes occurs with subsequent pancreatic failure.

Entities:  

Mesh:

Year:  1991        PMID: 1914819     DOI: 10.2337/diacare.14.7.685

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

1.  A novel (TA)n polymorphism in the hexokinase II gene: application to noninsulin-dependent diabetes mellitus in the Pima Indians.

Authors:  H Ardehali; G E Tiller; R L Printz; H Mochizuki; M Prochazka; D K Granner
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

2.  Postabsorptive respiratory quotient and insulin-stimulated glucose storage rate in nondiabetic pima indians are related To glycogen synthase fractional activity in cultured myoblasts.

Authors:  D M Mott; R E Pratley; C Bogardus
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

3.  Repeatability and reproducibility of the hyperinsulinemic-euglycemic clamp and the tracer dilution technique in a controlled inpatient setting.

Authors:  Duc Son N T Le; Thomas Brookshire; Jonathan Krakoff; Joy C Bunt
Journal:  Metabolism       Date:  2009-03       Impact factor: 8.694

4.  Abnormal regulation of ribosomal protein S6 kinase by insulin in skeletal muscle of insulin-resistant humans.

Authors:  J Sommercorn; R Fields; I Raz; R Maeda
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

5.  The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

Authors:  J Koska; E Ortega; J C Bunt; A Gasser; J Impson; R L Hanson; J Forbes; B de Courten; J Krakoff
Journal:  Diabetologia       Date:  2008-12-23       Impact factor: 10.122

6.  Molecular and linkage analysis of type-1 protein phosphatase catalytic beta-subunit gene: lack of evidence for its major role in insulin resistance in Pima Indians.

Authors:  M Prochazka; H Mochizuki; L J Baier; P T Cohen; C Bogardus
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

7.  Palmitate action to inhibit glycogen synthase and stimulate protein phosphatase 2A increases with risk factors for type 2 diabetes.

Authors:  David M Mott; Karen Stone; Mary C Gessel; Joy C Bunt; Clifton Bogardus
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-12-04       Impact factor: 4.310

8.  Harveian Oration 2016: Some observations on the causes and consequences of obesity.

Authors:  Stephen O'Rahilly
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.